-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
4D Molecular Therapeutics, Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
- 4D Molecular Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $90,000, a 2900% increase year-over-year.
- 4D Molecular Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending 30 Sep 2025 was $120,000, a 567% increase year-over-year.
- 4D Molecular Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $37,000, a 100% decline from 2023.
- 4D Molecular Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $20,723,000, a 562% increase from 2022.
- 4D Molecular Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $3,129,000, a 83% decline from 2021.